Effects of Ginkgo biloba extract on brain oxidative condition after cisplatin exposure

Duygu Aydin, Emine G G Peker, Meryem D Karakurt, Ayşe Gurel, Mustafa Ayyildiz, Şule C Cevher, Erdal Agar, Senol Dane


Purpose: The purpose of this study was to evaluate the efficacy of Ginkgo biloba extract (EGb 761) on oxidative events of brain in cisplatin-administrated rats.

Methods: Rats were divided into four experimental groups: 1) control (n=6); 2) cisplatin (8 mg/kg, intraperitoneally one dose, n=6); 3) EGb 761 (100 mg/kg intraperitoneally for 15 days, n=6); and 4) cisplatin + EGb 761 (n=6). After drug administration, rats were sacrificed and brain tissues were removed. Nitric oxide (NO), malondialdehyde (MDA) and glutathione (GSH) levels were evaluated in brain tissues.

Results: Single dose cisplatin administration significantly increased NO and GSH levels, but decreased MDA levels in brain tissue samples. EGb 761 treatment reversed the effects of cisplatin on NO and GSH levels, but did not affect the decreased MDA levels.

Conclusion: Results of the study indicate that oxidative stress can be an important pathogenetic mechanism of cisplatin-induced neurotoxicity. EGb 761, an standardized extract of G. biloba leaves that has antioxidant properties, may improve the oxidative stress-related neurological side effects of cisplatin.

Full Text:


DOI: http://dx.doi.org/10.25011/cim.v39i6.27511


  • There are currently no refbacks.

Comments on this article

View all comments

© 2007-2018 Canadian Society for Clinical Investigation.
C.I.M. provides open access to all of its content 6 months after the date of publication